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CASE REPORT
Fusobacterium necrophorum CAUSING INFECTIVE ENDOCARDITIS AND 
LIVER AND SPLENIC ABSCESSES
Marc Zac HANDLER(1), Benjamin MIRIOVSKY(1), Howard E. GENDELMAN & Uriel SANDKOVSKY(1,2)
SUMMARY
A 25-year-old male without prior co-morbidities was admitted to hospital with Fusobacterium necrophorum bacteremia, where he 
was found to have liver and splenic abscesses. Further evaluation with echocardiography revealed a bicuspid aortic valve with severe 
insufficiency and a 1.68 x 0.86 cm vegetation. The patient required abscess drainage, intravenous antimicrobial therapy and aortic 
valve replacement. Complete resolution of the infection was achieved after valve replacement and a prolonged course of intravenous 
antimicrobial therapy. A brief analysis of the patient’s clinical course and review of the literature is presented. 
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INTRODUCTION
Fusobacterium necrophorum is an obligate anaerobic filamentous 
gram-negative rod that frequently colonizes the mouth and respiratory 
tract. The classic clinical presentation of infection due to F. necrophorum 
is septic jugular thrombophlebitis (also called Lemierre’s syndrome) with 
findings of sore throat, persistent fever, soft tissue or neck swelling and 
bacteremia7. There is increasing evidence for F. necrophorum as a cause 
of endemic pharyngitis in adolescents and young adults with an estimated 
incidence that could parallel that of the group A Streptococcus5. F. 
necrophorum may also cause intraabdominal infections, peritonitis, septic 
arthritis, brain abscesses and less frequently, infective endocarditis (IE)6-9. 
CASE REPORT
A 25-year-old Caucasian male without significant past medical 
history and no history of alcohol or illicit drug use presented to the 
emergency room in December 2009 with a one week- history of sore 
throat, fever and chills, nausea, vomiting and watery diarrhea. He was 
given hydration and sent home. Two days later he was seen at his primary 
care provider’s office where he was diaphoretic, febrile to 39 oC and 
hypotensive, and he was admitted to an outside hospital. On admission, 
his temperature was 39.2 oC, heart rate 99 beats per minute, blood pressure 
137/80, and respirations 18 per minute. Physical examination showed 
a well nourished man with mild oropharynx edema without tonsillar 
drainage and no evidence of neck swelling. Lungs were clear and heart 
examination was notable for a 2/6 diastolic murmur best appreciated on 
the lower right sternal border. The abdomen was benign without palpable 
spleen or liver or tenderness and there were no skin or mucosal lesions 
present on examination. The patient’s WBC count was 24,000 cells/
mm3, platelets 28000/mm3, creatinine 2.7 mg/dL (0.6-1.3) and BUN 41 
mg/dL. Liver tests showed AST 44 U/L (10-40), ALT 48 U/L (30-65), 
albumin 2.2 mg/dL (3.5-5), alkaline phosphatase 210 U/L (43-138), total 
bilirubin 4.1 mg/dL (0-1.5) with direct bilirubin 3.6 mg/dL, and CRP 
222 mg/dL (0.5-9 mg/dL). Two anaerobic blood culture bottles drawn 
on admission turned positive at 16 and 17 hours. Anaerobe phenylethyl 
alcohol blood agar (PEA), anaerobe kanamycin-vancomycin blood agar 
(KV) and enriched thioglycolate medium for anaerobes (THIO) were 
used and subsequently grew beta-lactamase negative Fusobacterium 
necrophorum. Intravenous piperacillin-tazobactam 3.375 grams every 
six hours was initiated with sterilization of subsequent blood cultures. 
Initial computed tomography (CT) scans of the chest and abdomen 
performed without intravenous contrast showed no vascular lesions. There 
was splenomegaly and a 2 cm hypodense lesion on the right hepatic lobe. 
Ultrasound Doppler of the neck showed patent right neck veins although 
the left side was not evaluated. A CT scan of the neck - also without 
intravenous contrast - showed soft tissue swelling posterior to the right 
parotid gland but no other abnormalities. Ultrasound examination of 
the liver showed a 2.5 cm complex fluid collection on the right hepatic 
lobe. On the third hospital day the patient developed abdominal pain and 
persisted febrile despite proper antimicrobial therapy and a repeat CT scan 
of the abdomen showed two splenic lesions of 1.2 and 1.3 cm in diameter 
and a 3 cm complex liver lesion all of which enhanced with intravenous 
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contrast, suggestive of abscesses. The liver lesion was aspirated five 
days after the start of antimicrobial therapy. Primarily due to concerns 
of thrombocytopenia, drainage was delayed. Blood cultures obtained at 
that time did not show bacterial growth. A transthoracic echocardiogram 
evidenced a bicuspid aortic valve with severe regurgitation but failed to 
show vegetations; however, a transesophageal echocardiogram (TEE) 
revealed severe aortic insufficiency and 1.68 x 0.86 cm mobile vegetation 
on the aortic valve (Fig. 1). Ten days into admission the patient’s fever 
recurred with a recorded temperature of 40.3 oC. Re-evaluation of the 
abdomen with a CT scan showed a stable 3 cm liver abscess but an 
enlarged splenic fluid collection of 3 x 1.8 cm (Fig. 2 and 3). External 
drainage catheters were placed into both the splenic and hepatic lesions 
with resolution of the fever. On his third week of hospitalization he was 
transferred to the Nebraska Medical Center. A repeat TEE showed a 
smaller vegetation of ~ 7 mm on the aortic valve. He underwent aortic 
valve replacement with a mechanical valve. He was discharged to 
complete six weeks of antimicrobial therapy with 24 million units a day 
of penicillin G after surgery. Follow-up imaging showed resolution of 
the liver and splenic abscesses. The patient continues to follow in the 
outpatient clinic regularly and has not had any relapses. 
DISCUSSION
F. necrophorum is an obligate anaerobic filamentous gram-negative 
rod that frequently colonizes the mouth and respiratory tract. The classic 
clinical presentation of infection due to F. necrophorum is septic jugular 
thrombophlebitis (also called Lemierre’s syndrome) with findings of 
sore throat, persistent fever, soft tissue or neck swelling and bacteremia7. 
There is increasing evidence for F. necrophorum as a cause of endemic 
pharyngitis in adolescents and young adults with an estimated incidence 
that could parallel the one for group A Streptococcus5. F. necrophorum 
may also cause intraabdominal infections, peritonitis, septic arthritis, 
brain abscesses and, less frequently, as in this case, infective endocarditis 
(IE)6-9. 
Anaerobic bacteria represent 1-16% of all cases of infective 
endocarditis4. Of the reported cases of Fusobacterium spp IE, 77 percent 
seeded from head and neck infections and 20 percent occurred in the 
setting of IV drug use. Most cases of IE caused by F. necrophorum have 
originated from the head and neck with one reported case in a patient 
with polymicrobial IE secondary to intravenous drug use (IVDU)1, 6, 9, 12. 
Interestingly, a recent report of a fatal case of mitral valve endocarditis 
caused by F. necrophorum in a 20 year-old female without clinical or post-
mortem autopsy findings that could point to an originating source2. Our 
patient had complained of a sore throat before admission to the hospital 
and imaging of the neck, although limited by the lack of intravenous 
contrast, did not show major or obvious findings. Moreover, there was 
no history of head and neck procedures that could have pointed to an 
originating source and nor did he use illicit drugs. 
Although F. necrophorum is well known to cause septic embolization 
to distant sites, IE is still an uncommon finding. On the few reported cases 
of F. necrophorum endocarditis that have been identified, complications 
included heart failure, lung, liver, spleen and brain embolization, rapid 
valve destruction and death1,9,11,12. Table 1 summarizes the previously 
reported cases of IE caused by F. necrophorum. Anaerobic bacterial 
endocarditis has been associated with lower frequency of preexisting 
valvular heart disease when compared to endocarditis caused by aerobic 
bacteria3. Our patient did have preexisting valvular heart disease (bicuspid 
aortic valve) that may have increased his risk substantially. The overall 
mortality for patients with anaerobic IE ranges between 21-43%4. 
Endocarditis due to F. necrophorum has been initially associated with a 75 
percent mortality rate4,9,11,12. Of the previously reported cases summarized 
in Table 1, it is interesting to note that almost half of them originated in 
the oropharynx, the left side of the heart was more commonly involved, 
almost half of them had embolic complications, three underwent valve 
replacement and the overall mortality rate was 50 percent if we exclude 
the three cases in which the outcome was unknown. Fatalities may 
be lower nowadays with the availability and prompt use of effective 
antimicrobial therapy, but the low number of reported cases and the 
lack of clinical studies may preclude any assumption. HUGGAN & 
MURDOCH identified 25 invasive infections caused by F. necrophorum 
among 78 clinical isolates with no reported fatalities, although no cases 
of IE were identified in this report8. 
Clinical diagnosis should be suspected with the finding of high 
fever and rigors in patients with a history of sore throat, jugular vein 
thrombosis and septic embolization. Making the correct diagnosis may 
still prove to be difficult, even with the classic presentation of Lemierre’s 
syndrome, because the disease is not usually suspected. The appearance 
of the throat may vary from normal to severe exudative tonsillitis and the 
neck vein thrombosis may be mistaken for cervical lymphadenopathy. 
Septic manifestations tend to occur several days after the sore throat 
has resolved and may also be initially attributed to other pathogens (i.e 
cavitary lung lesions caused by Staphylococcus aureus). Imaging studies 
Fig. 1 - Above transesophageal echocardiogram showing an aortic valve vegetation. Figures 
2 and 3 below: computed tomography of the abdomen demonstrating a liver abscess (green 
arrowhead) and splenic abscess (red arrowhead).
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such as ultrasound with doppler or CT scans of the neck may prove useful 
since jugular vein involvement is not readily recognized in clinical exam. 
Isolating the bacterium from clinical specimens is key for microbiological 
diagnosis. Growth is usually achieved with special media consisting of 
blood agar enriched with hemin, vitamin K, menadione and a reducing 
agent. The colonies appear cream-yellow in color with almost all strains 
showing complete hemolysis in horse blood agar. Full identification 
can be completed with biochemical tests available in commercial kits10. 
Treatment often involves surgical debridement of necrotic tissues 
Table 1
Summary of the reported case of infective endocarditis due to F. necrophorum
Authors Age (years) and 
gender
Possible predisposing 
factors
Valve involved and 
complications
Treatment Outcome 
NASTRO & 
FINEGOLD9
52, male Dental fistula Aortic valve, splenic 
emboli
No therapy Death 
21, male Tonsillar abscesses Mitral valve, emboli to 
skin, joint, liver, lung
No therapy Death
37, unknown Unknown Mitral valve, CHF Penicillin 
No valve replacement
Death
Not stated Not stated Not stated Not stated Not stated
Adult female, age 
unknown
Suppurative 
tonsillitis
Ao valve No therapy Death
27, male Pyorrhea Valve unspecified, 
thrombophlebitis, 
emboli to brain and 
brain abscess 
Hetacillin 
No mention of valve 
replacement
Alive
47 male Pneumonia, 
empyema, subphrenic 
abscess
Valve unspecified, 
Emboli to axillary 
artery, liver
Methicillin 
No mention of valve 
replacement
Alive
FELNER &  
DOWELL6
Adult, unknown Oropharyngeal disease Unknown Not mentioned Unknown
Adult, unknown Oropharyngeal disease Unknown Not mentioned Unknown
ADLER et al.1 39, male IVDU. Tricuspid valve 
polymicrobial 
endocarditis, CHF 
subclavian abscess
Initial 
Nafcillin+gentamicin 
then changed to 
penicillin and later 
Ampicillin and 
metronidazole 
Valve replacement
Alive 
STUART & WREN11 2, male Unknown Mitral valve, 
pneumonia with 
empyema
Initially Azlocillin 
and gentamicin. 
Later ceftazidime, 
vancomycin and 
metroinidazole. 
Delayed valve 
replacement
Alive
VEDIRE et al.12 20, male Unable to identify Aortic valve, 
pulmonary edema
Piperacillin-tazobactam 
subsequently changed to 
Penicillin G. No valve 
replacement
Alive
AUGUSTO, et al.2 20, female Unable to identify Mitral valve,
 pulmonary edema
Cefotaxime and 
levofloxacin 
Valve replacement
Death
CHF: congestive heart failure; IVDU: intravenous drug abuse.
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or drainage of abscesses. Because many F. necrophorum infections are 
polymicrobial and F. necrophorum may be penicillin resistant, initial 
antimicrobial therapy for life threatening cases should include a beta-
lactam plus beta lactamase inhibitor such as piperacillin-tazobactam, a 
carbapenem or metroinidazole and either a penicillin or third generation 
cephalosporin4,7,10. Some authorities prefer to use metronidazole due to 
its excellent in-vitro activity, good tissue penetration and the possibility 
to switch to oral therapy. Duration of treatment varies depending on 
the site and severity of infection, although treatment courses of less 
than two weeks have been associated with relapses. Despite the lack of 
prospective studies, it would seem prudent to complete at least six weeks 
of antimicrobial therapy in cases of endocarditis like in our patient.
Similar to the case described by AUGUSTO et al.2, we were unable 
to determine the originating source of our patient’s bacteremia but we 
could also speculate that this patient’s infection may have arisen from 
endemic pharyngitis. 
This case serves as a reminder of the elusive clinical presentation 
of this particularly virulent organism, especially in the initial stages, the 
rapid clinical progression and the potential complications that can arise 
from this infection. Bacteremia caused by F. necrophorum has a high 
mortality rate especially due to the lack of specific signs and symptoms 
upon initial presentation. Morbidity and mortality is further increased 
by the presence of deep seated infections or endocarditis. Antimicrobial 
therapy alone may be insufficient with many patients often requiring 
surgical intervention. It is also important to remember that patients can 
present with bacteremia even without the classic history of IV drug abuse, 
head and neck procedures or the presence of oropharyngeal disease. 
RESUMO
Fusobacterium necrophorum causando endocardite infecciosa e 
abscesso hepático e esplênico
Homem de 25 anos de idade, sem antecedentes mórbidos foi admitido 
ao hospital com bacteremia por Fusobacterium necrophorum e abscessos 
no fígado e no baço. Avaliação posterior com ecografia revelou válvula 
aórtica bicúspide com insuficiência severa e vegetação de 1,68 x 0,86 
cm. Foi feita drenagem dos abscessos, terapia antimicrobiana intravenosa 
e substituição da válvula aórtica. Resolução completa da infecção foi 
conseguida após substituição valvular e curso prolongado de terapêutica 
intravenosa antimicrobiana. É apresentada breve análise do curso clínico 
do paciente e revisão da literatura. 
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